New brain scans aim to uncover why dravet patients face higher sudden death risk
NCT ID NCT07013331
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study uses PET and MRI scans to look at serotonin pathways in the brainstem of adults with Dravet syndrome, a severe form of epilepsy. Researchers want to see if these pathways are different in Dravet patients compared to those with other drug-resistant epilepsy and healthy people. The goal is to better understand why Dravet syndrome carries a high risk of sudden unexpected death in epilepsy (SUDEP). The study involves 30 participants: 10 with Dravet syndrome, 10 with focal epilepsy, and 10 healthy volunteers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRAVET SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Neurologique Pierre Wertheimer
RECRUITINGBron, Rhone, 69500, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Zapping the brain from outside the skull: a new hope for Drug-Resistant epilepsy?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can community hospitals in zambia master severe disease care?
- Can mindfulness rewire the mind to lift depression in epilepsy?
- A break from seizure pills: could less medication mean better living?
- Can invisible electric fields quiet the Brain's seizure signals?